Krebs Biochemicals & Industries Limited announced that the Board of Directors of the Company at its meeting held on February 3, 2023, approved the appointment of Mr. Ritesh Jain as Chief Financial Officer (CFO) and Key Managerial Personnel of the Company with effect from February 3, 2023 and Resignation of Mr. Ravi Babu as Chief Financial Officer and Key Managerial Personnel of the Company from the closure of business hours on February 3, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.03 INR | -2.71% | -3.25% | -11.88% |
1st Jan change | Capi. | |
---|---|---|
-11.88% | 18.33M | |
+18.67% | 43.74B | |
+23.60% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-9.18% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.47B |
- Stock Market
- Equities
- 524518 Stock
- News Krebs Biochemicals & Industries Limited
- Krebs Biochemicals & Industries Limited Approves CFO Changes